JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.13% |
| 2 | Financials | 11.98% |
| 3 | Healthcare | 9.78% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RBNC
4901
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $55K | ﹤0.01% |
2,465
-115
| -4% | -$2.56K |
|
4902
WisdomTree US SmallCap Earnings Fund
EES
$730M
| $54K | ﹤0.01% |
1,500
| – | – |
|
|
KZR
4903
DELISTED
Kezar Life Sciences
KZR
| $54K | ﹤0.01% |
306
+174
| +132% | +$34.3K |
|
4904
Omega Flex
OFLX
$304M
| $54K | ﹤0.01% |
710
-3,315
| -82% | -$227K |
|
4905
TFS Financial
TFSL
$4.89B
| $54K | ﹤0.01% |
3,270
+220
| +7% | +$3.68K |
|
4906
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.33B
| $54K | ﹤0.01% |
776
| – | – |
|
4907
Cadiz
CDZI
$292M
| $53K | ﹤0.01% |
5,516
-259
| -4% | -$2.58K |
|
4908
i3 Verticals
IIIV
$323M
| $53K | ﹤0.01% |
2,223
+251
| +13% | +$5.84K |
|
4909
VanEck Pharmaceutical ETF
PPH
$990M
| $53K | ﹤0.01% |
880
-907
| -51% | -$53.6K |
|
4910
SmartFinancial
SMBK
$898M
| $53K | ﹤0.01% |
2,809
-94
| -3% | -$1.8K |
|
4911
Spyre Therapeutics
SYRE
$9.18B
| $53K | ﹤0.01% |
267
+99
| +59% | +$20.6K |
|
|
NYMX
4912
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $53K | ﹤0.01% |
26,913
+1,098
| +4% | +$2.33K |
|
4913
Coda Octopus Group
CODA
$116M
| $52K | ﹤0.01% |
+5,590
| New | +$41.1K |
|
4914
Gold Fields
GFI
$36.4B
| $52K | ﹤0.01% |
13,933
-295,138
| -95% | -$1.14M |
|
4915
Green Brick Partners
GRBK
$3.02B
| $52K | ﹤0.01% |
5,985
-281
| -4% | -$2.42K |
|
4916
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $52K | ﹤0.01% |
2,880
+1,222
| +74% | +$23.6K |
|
4917
Arq
ARQ
$100M
| $52K | ﹤0.01% |
4,510
-211
| -4% | -$2.41K |
|
|
ONIT
4918
Onity Group
ONIT
$321M
| $52K | ﹤0.01% |
1,912
-89
| -4% | -$2.5K |
|
|
MLVF
4919
DELISTED
Malvern Bancorp, Inc.
MLVF
| $52K | ﹤0.01% |
2,564
-2,323
| -48% | -$47.7K |
|
|
CNST
4920
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $52K | ﹤0.01% |
3,848
+1,779
| +86% | +$15.9K |
|
|
ACB
4921
PUT
Aurora Cannabis
ACB
$237M
| $51K | ﹤0.01% |
+47
| New | +$42K |
|
4922
Amerant Bancorp
AMTB
$1.15B
| $51K | ﹤0.01% |
+3,690
| New | +$52.9K |
|
4923
Ardmore Shipping
ASC
$681M
| $51K | ﹤0.01% |
8,241
-383
| -4% | -$2.1K |
|
4924
iShares MSCI BIC ETF
BKF
$77M
| $51K | ﹤0.01% |
1,187
| – | – |
|
4925
Evolus
EOLS
$536M
| $51K | ﹤0.01% |
2,271
-107
| -4% | -$2.31K |
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,671 reduced and 538 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 538 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.